All In Biotech

Drug Trial Radar · NCT05776069

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

A Multi-Modular Trial to Evaluate VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease and Other Bleeding Disorders (VIVID)

Last checked: Nov 19, 2026Latest source record: Aug 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 116 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

116

Planned (sponsor's estimate)

Start

Mar 16, 2023

Primary completion

Dec 2029

Study completion Dec 2029

Sponsor

Lead sponsor
Vega Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Mar 20, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The VIVID study is structured in a master protocol format comprised of multiple parts that evaluate intravenous (IV) and subcutaneous (SC) VGA039 in healthy volunteers and subjects with von Willebrand Disease (VWD) and other bleeding disorders.

Conditions

  • Von Willebrand Diseases

Interventions

  • VGA039Drug

    Single doses of VGA039

  • PlaceboOther

    Single doses of Placebo

  • VGA039Drug

    Multiple doses of VGA039

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-Emergent Adverse Events [Safety and tolerability]Time frame: From start of study drug administration until 15 or 8 weeks after IV or SC study drug administration, respectively

Locations

25 sites in 8 countries. Site status is shown where the registry gives one.

  • Orthopedic Institute for Children (UCLA)

    Los Angeles, California · Recruiting

  • UC Davis Medical Center

    Sacramento, California · Recruiting

  • University of Colorado School of Medicine

    Aurora, Colorado · Recruiting

  • Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory

    Atlanta, Georgia · Recruiting

  • Science 37, Inc.

    Morrisville, North Carolina · Recruiting

  • Hemophilia Center of Western PA

    Pittsburgh, Pennsylvania · Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Recruiting

  • University of Texas Southwestern

    Dallas, Texas · Recruiting

  • Washington Center for Bleeding Disorders

    Seattle, Washington · Recruiting

  • Versiti Comprehensive Center for Bleeding Disorders

    Milwaukee, Wisconsin · Recruiting

  • Royal Brisbane & Women's Hospital, Queensland Haemophilia Centre

    Herston, Queenland, Australia · Recruiting

  • Medical University of Vienna

    Vienna, State of Vienna, Austria · Completed

  • Centro de Hemoterapia e Hematologia do Rio de Janeiro HEMORIO

    Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting

  • Hemocentro Unicamp

    Campinas, São Paulo, Brazil · Recruiting

  • Hospital das Clinicas - USP Endereco

    São Paulo, São Paulo, Brazil · Recruiting

  • Hamilton Health Sciences Corporation

    Hamilton, Ontario, Canada · Recruiting

  • Queens University

    Kingston, Ontario, Canada · Recruiting

  • St. Michaels Hospital

    Toronto, Ontario, Canada · Recruiting

  • K J Somaiya Super Speciality Hospital & Research Centre

    Sion, Mumbai, India · Recruiting

  • Charlotte Maxeke Johannesburg Academic Hospital

    Johannesburg, South Africa · Recruiting

  • Imperial College Healthcare NHS Trust- Queen Charlotte's & Chelsea Hospital

    London, United Kingdom · Recruiting

  • Queen Elizabeth Hospital Birmingham

    Birmingham, Edgbaston, United Kingdom · Recruiting

  • University Hospital Southampton NHS Foundation Trust

    Southampton, Hampshire, United Kingdom · Recruiting

  • Royal Free Hospital

    London, London, United Kingdom · Recruiting

  • Royal London Hospital, Clinical Haematology Research

    Whitechapel, London, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.